Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Recknor Chris P, Chief Executive Officer. Insider active across 1 company, notably CytoDyn Inc.. In total, 2 disclosures have been logged. Activity tracked since 6 August 2021. The latest transaction was filed on 31 March 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Chris P. Recknor is the Chief Operating Officer at CytoDyn Inc. He is responsible for overseeing the company's operations, ensuring efficiency and process optimization. With a strong background in the biopharmaceutical sector, he plays a key role in implementing operational strategy.